<p>2025 年 4 月 14 日- 下午 4:35</p>
<p>纽约，纽约，2025 年 4 月 14 日（GLOBE NEWSWIRE）-- Denali Capital Acquisition Corp.（纳斯达克：DECA）（“公司”）今天宣布，2025 年 4 月 11 日，公司股东投票通过了对公司修订和重述的备忘录及章程（“章程”）的修订，以将公司必须完成首次业务合并的日期从 2025 年 4 月 11 日延长至 2025 年 12 月 11 日，选择每月延长一次，最多可延长八次，每次延长一个月（“延长”）。</p>
<p>公司还今天宣布，2025 年 4 月 11 日，公司向公司的信托账户（“信托账户”）存入了 874.78 美元，代表未在特别股东大会上进行赎回的每股公众股份 0.02 美元的金额。该存款通过公司向 Scilex Holding Company（纳斯达克：SCLX，“Scilex”）发行的本金最高为 180,000 美元的现有可转换票据进行融资，该票据不计利息，并在公司首次业务合并的生效日期或公司清算日期之前偿还。在业务合并完成时，该票据可由 Scilex 自行决定转换为公司 A 类普通股，转换价格为每股 10.00 美元。预计未来对可转换票据剩余本金的提款将用于必要的未来一个月的延长，以提供额外时间让公司完成业务合并。</p>
<p>关于投票结果的完整报告将以 8-K 表格提交给美国证券交易委员会（“SEC”）。</p>
<p><strong>关于公司</strong></p>
<p>Denali Capital Acquisition Corp.是一家空白支票公司，注册为开曼群岛的豁免公司，旨在与一个或多个企业或实体进行合并、股份交换、资产收购、股份购买、重组或类似的业务合并。</p>
<p><strong>征集参与者</strong></p>
<p>公司、其董事和高管及其他人员可能被视为在征集公司股东关于延长的代理投票方面的参与者。有关公司董事和高管的信息可在其向 SEC 提交的 10-K 年度报告中找到。关于根据 SEC 规则可能被视为代理征集参与者的人员及其直接和间接利益的描述包含在与股东大会相关的最终代理声明（“最终代理声明”）中。</p>
<p><strong>无报价或征集</strong></p>
<p>本通讯不构成对任何证券的代理、同意或授权的征集。本通讯也不构成出售或征集购买任何证券的报价，也不应在任何州或司法管辖区进行证券的销售，除非在该等司法管辖区的证券法下注册或合格之前。证券的任何发行应仅通过符合 1933 年证券法第 10 条要求的招股说明书或其豁免进行。</p>
<p><strong>附加信息及获取途径</strong></p>
<p>2025 年 3 月 27 日，公司向 SEC 提交了最终代理声明，以征集股东大会的代理投票。公司投资者和证券持有者被敦促在最终代理声明（包括任何修订或补充）及公司向 SEC 提交的其他文件可用时仔细阅读，因为这些文件将包含重要信息。投资者和证券持有者可以通过 SEC 维护的网站 www.sec.gov 或向公司的代理征集人 Advantage Proxy, Inc.提出请求，获取最终代理声明（包括任何修订或补充）及其他向 SEC 提交的文件的免费副本，地址为 P.O. Box 10904 Yakima, WA 98909，免费电话（877）870-8565 或收费电话（206）870-8565，电子邮件：ksmith@advantageproxy.com。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含涉及风险和不确定性的前瞻性声明。前瞻性声明受多种条件、风险和情况变化的影响，其中许多超出了公司的控制，包括在公司最近的 10-K 年度报告和向证券交易委员会提交的 10-Q 季度报告中的 “风险因素” 部分中列出的因素。公司明确否认任何义务或承诺，公开发布任何前瞻性声明的更新或修订，以反映公司对此的期望变化或任何声明所基于的事件、条件或情况的变化。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RReU1qSTFOQ00yT0RZMk1qazFJelV3TURFeU16YzROUT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RReU1qSTFOQ00yT0RZMk1qazFJelV3TURFeU16YzROUT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDIwOTM2ZWEtM2QyMC00MTJjLWIwOGYtNjZkZTZlMmFkYjlhLTUwMDEyMzc4NS0yMDI1LTA0LTE0LWVu/tiny/Denali-Capital-Acquisition-Cor.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDIwOTM2ZWEtM2QyMC00MTJjLWIwOGYtNjZkZTZlMmFkYjlhLTUwMDEyMzc4NS0yMDI1LTA0LTE0LWVu/tiny/Denali-Capital-Acquisition-Cor.png"/></p>
<pre><code> 联系信息：646-978-3133
</code></pre>

DECAU

DECA

DNQUF

DNQAF

SMNR

<p>Denali Capital Acquisition Corp.（纳斯达克代码：DECA）宣布，股东批准将完成初始业务合并的截止日期从 2025 年 4 月 11 日延长至 2025 年 12 月 11 日。该延长允许每月最多延长八次。公司还向其信托账户存入了 874.78 美元，这笔资金来自 Scilex Holding Company 的可转换票据。将向美国证券交易委员会（SEC）提交一份 8-K 表格的当前报告，详细说明投票结果</p>

<p>04/14/2025 - 04:35 PM</p>
<div class="lb-trans"><p>2025 年 4 月 14 日- 下午 4:35</p>
</div><p>NEW YORK, NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- Denali Capital Acquisition Corp. (NASDAQ:DECA) (the &#34;Company&#34;) announced today that on April 11, 2025, the Company's shareholders voted in favor of approving amendments to the Company's amended and restated memorandum and articles of association (the &#34;Articles&#34;) to extend the date by which the Company must consummate an initial business combination from April 11, 2025 to December 11, 2025 by electing to extend the date to consummate an initial business combination on a monthly basis for up to eight times by an additional one month each time (the &#34;Extension&#34;).</p>
<div class="lb-trans"><p>纽约，纽约，2025 年 4 月 14 日（GLOBE NEWSWIRE）-- Denali Capital Acquisition Corp.（纳斯达克：DECA）（“公司”）今天宣布，2025 年 4 月 11 日，公司股东投票通过了对公司修订和重述的备忘录及章程（“章程”）的修订，以将公司必须完成首次业务合并的日期从 2025 年 4 月 11 日延长至 2025 年 12 月 11 日，选择每月延长一次，最多可延长八次，每次延长一个月（“延长”）。</p>
</div><p>The Company also announced today that on April 11, 2025, the Company deposited into the Company's trust account (the “Trust Account”) $874.78, representing the $0.02 per public share issued and outstanding that were not delivered for redemption in connection with the extraordinary general meeting.This deposit was funded via the Company’s existing convertible promissory note with a principal amount of up to $180,000 issued by the Company to Scilex Holding Company (Nasdaq: SCLX, “Scilex”), which bears no interest and is repayable on the earlier of the effective date of the consummation of the Company’s initial business combination or the date of the liquidation of the Company. Upon the closing of a business combination, the note is convertible, at Scilex’s discretion, into the Company’s Class A ordinary shares at a conversion price of $10.00 per share. Any future drawdowns of the remaining $ principal amount available under the convertible promissory note are expected to fund future one-month extensions as necessary to provide additional time for the Company to complete a business combination.</p>
<div class="lb-trans"><p>公司还今天宣布，2025 年 4 月 11 日，公司向公司的信托账户（“信托账户”）存入了 874.78 美元，代表未在特别股东大会上进行赎回的每股公众股份 0.02 美元的金额。该存款通过公司向 Scilex Holding Company（纳斯达克：SCLX，“Scilex”）发行的本金最高为 180,000 美元的现有可转换票据进行融资，该票据不计利息，并在公司首次业务合并的生效日期或公司清算日期之前偿还。在业务合并完成时，该票据可由 Scilex 自行决定转换为公司 A 类普通股，转换价格为每股 10.00 美元。预计未来对可转换票据剩余本金的提款将用于必要的未来一个月的延长，以提供额外时间让公司完成业务合并。</p>
</div><p>A Current Report on Form 8-K disclosing the full voting results will be filed with the U.S. Securities and Exchange Commission (the “SEC”).</p>
<div class="lb-trans"><p>关于投票结果的完整报告将以 8-K 表格提交给美国证券交易委员会（“SEC”）。</p>
</div><p><strong>About the Company</strong></p>
<div class="lb-trans"><p><strong>关于公司</strong></p>
</div><p>Denali Capital Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.</p>
<div class="lb-trans"><p>Denali Capital Acquisition Corp.是一家空白支票公司，注册为开曼群岛的豁免公司，旨在与一个或多个企业或实体进行合并、股份交换、资产收购、股份购买、重组或类似的业务合并。</p>
</div><p><strong>Participants in the Solicitation</strong></p>
<div class="lb-trans"><p><strong>征集参与者</strong></p>
</div><p>The Company, its directors and executive officers and other persons may be deemed to be participants in the solicitation of proxies from the Company's shareholders in respect of the Extension. Information regarding the Company's directors and executive officers is available in its Annual Report on Form 10-K filed with the SEC. Additional information regarding the persons who may, under the rules of the SEC, be deemed participants in the proxy solicitation and a description of their direct and indirect interests are contained in the definitive proxy statement relating to the Shareholder Meeting (the &#34;Definitive Proxy Statement&#34;).</p>
<div class="lb-trans"><p>公司、其董事和高管及其他人员可能被视为在征集公司股东关于延长的代理投票方面的参与者。有关公司董事和高管的信息可在其向 SEC 提交的 10-K 年度报告中找到。关于根据 SEC 规则可能被视为代理征集参与者的人员及其直接和间接利益的描述包含在与股东大会相关的最终代理声明（“最终代理声明”）中。</p>
</div><p><strong>No Offer or Solicitation</strong></p>
<div class="lb-trans"><p><strong>无报价或征集</strong></p>
</div><p>This communication shall not constitute a solicitation of a proxy, consent or authorization with respect to any securities. This communication shall also not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or an exemption therefrom.</p>
<div class="lb-trans"><p>本通讯不构成对任何证券的代理、同意或授权的征集。本通讯也不构成出售或征集购买任何证券的报价，也不应在任何州或司法管辖区进行证券的销售，除非在该等司法管辖区的证券法下注册或合格之前。证券的任何发行应仅通过符合 1933 年证券法第 10 条要求的招股说明书或其豁免进行。</p>
</div><p><strong>Additional Information and Where to Find it</strong></p>
<div class="lb-trans"><p><strong>附加信息及获取途径</strong></p>
</div><p>On March 27, 2025, the company filed the Definitive Proxy Statement with the SEC in connection with its solicitation of proxies for the Shareholder Meeting. INVESTORS AND SECURITY HOLDERS OF THE COMPANY ARE URGED TO READ THE DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND OTHER DOCUMENTS THE COMPANY FILES WITH THE SEC CAREFULLY IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders will be able to obtain free copies of the Definitive Proxy Statement (including any amendments or supplements thereto) and other documents filed with the SEC through the web site maintained by the SEC atwww.sec.gov or by directing a request to the Company's proxy solicitor, Advantage Proxy, Inc., at P.O. Box 10904 Yakima, WA 98909, Toll-Free (877) 870-8565 or Collect (206) 870-8565, Email:ksmith@advantageproxy.com</p>
<div class="lb-trans"><p>2025 年 3 月 27 日，公司向 SEC 提交了最终代理声明，以征集股东大会的代理投票。公司投资者和证券持有者被敦促在最终代理声明（包括任何修订或补充）及公司向 SEC 提交的其他文件可用时仔细阅读，因为这些文件将包含重要信息。投资者和证券持有者可以通过 SEC 维护的网站 www.sec.gov 或向公司的代理征集人 Advantage Proxy, Inc.提出请求，获取最终代理声明（包括任何修订或补充）及其他向 SEC 提交的文件的免费副本，地址为 P.O. Box 10904 Yakima, WA 98909，免费电话（877）870-8565 或收费电话（206）870-8565，电子邮件：ksmith@advantageproxy.com。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release includes forward looking statements that involve risks and uncertainties. Forward-looking statements are subject to numerous conditions, risks and changes in circumstances, many of which are beyond the control of the Company, including those set forth in the &#34;Risk Factors&#34; section of the Company's most recent annual report on Form 10-K and quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. The Company expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Company's expectations with respect thereto or any change in events, conditions or circumstances on which any statement is based.</p>
<div class="lb-trans"><p>本新闻稿包含涉及风险和不确定性的前瞻性声明。前瞻性声明受多种条件、风险和情况变化的影响，其中许多超出了公司的控制，包括在公司最近的 10-K 年度报告和向证券交易委员会提交的 10-Q 季度报告中的 “风险因素” 部分中列出的因素。公司明确否认任何义务或承诺，公开发布任何前瞻性声明的更新或修订，以反映公司对此的期望变化或任何声明所基于的事件、条件或情况的变化。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RReU1qSTFOQ00yT0RZMk1qazFJelV3TURFeU16YzROUT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTQyMjI1NCM2ODY2Mjk1IzUwMDEyMzc4NQ=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MDIwOTM2ZWEtM2QyMC00MTJjLWIwOGYtNjZkZTZlMmFkYjlhLTUwMDEyMzc4NS0yMDI1LTA0LTE0LWVu/tiny/Denali-Capital-Acquisition-Cor.png" alt="" original-src="https://ml.globenewswire.com/media/MDIwOTM2ZWEtM2QyMC00MTJjLWIwOGYtNjZkZTZlMmFkYjlhLTUwMDEyMzc4NS0yMDI1LTA0LTE0LWVu/tiny/Denali-Capital-Acquisition-Cor.png"/></p>
<pre><code>Contact Info: 646-978-3133
</code></pre>
<div class="lb-trans"><pre><code> 联系信息：646-978-3133
</code></pre>
</div>

Denali Capital Acquisition Corp. Announces Shareholder Approval of Extension of Deadline to Complete Business Combination  | DECA Stock News

StockTitan

Denali Capital Acquisition - UNIT

Denali Capital Acquisition

DENALI CAPITAL ACQUISITION CORP UNIT 1 ORD A & 1 WT EXP (28/03/2027)

DENALI CAPITAL ACQUISITION CORP

Semnur Pharmaceuticals, Inc.

Scilex

Denali Capital Acquisition Corp.宣布股东已批准延长完成业务合并的最后期限 | DECA 股票新闻